What is Eversight?
Eversight operates as a multifaceted nonprofit entity, functioning as both a premier eye bank and a comprehensive research partner. With a legacy spanning over 75 years, the organization is instrumental in the global fight against blindness, specifically targeting the 12 million individuals suffering from corneal conditions. By integrating clinical transplantation services with cutting-edge research at its Cleveland-based facility, Eversight bridges the gap between donor generosity and medical necessity. Its operational footprint, which spans several U.S. states and extends into South Korea, allows for a highly scalable approach to eye banking, ensuring that high-quality tissue is available for surgeons and academic medical centers worldwide. The organization is not merely a logistics provider but a catalyst for innovation in ophthalmology, providing the biofluids and tissue necessary for impactful scientific studies.
How much funding has Eversight raised?
Eversight has raised a total of $25.2M across 3 funding rounds:
Series A
$9.7M
Private Equity
$14.5M
Private Equity
$1M
Series A (2014): $9.7M with participation from Emergence Capital Partners
Private Equity (2016): $14.5M led by Sutter Hill Ventures and Emergence Capital Partners
Private Equity (2016): $999K, investors not publicly disclosed
Key Investors in Eversight
Emergence Capital Partners
Emergence is a leading venture capital firm focused on early-stage enterprise companies, dedicated to partnering with organizations that fundamentally change how the world operates.
Sutter Hill Ventures
Sutter Hill Ventures is a Palo Alto-based firm specializing in financing technology-driven startups and providing strategic guidance to help entrepreneurs build market-leading companies.
What's next for Eversight?
Looking ahead, the infusion of capital positions Eversight to further decentralize its eye banking model and expand its humanitarian reach into underserved international markets. The organization is expected to prioritize the development of sustainable, culturally informed infrastructures that empower local leaders to manage their own vision health resources. Furthermore, the continued investment will likely accelerate the Eversight Center for Vision and Eye Banking Research's capacity to conduct large-scale clinical trials. By fostering deeper collaborations with global academic institutions, Eversight aims to refine transplantation techniques and explore new therapeutic avenues for preventing blindness. This strategic roadmap ensures that the organization remains at the forefront of medical innovation, effectively utilizing its financial backing to transform the landscape of global eye care and research.
See full Eversight company page
